CX-2029
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CX-2029, covering 2024-01-23 to 2024-01-23. Get the full timeline:
Most recent: Clinical Trial Update: PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL [Phase 1, Phase 2]